Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Predictors of smoking relapse in a sample of Dutch adult smokers; the roles of gender and action plans.

Hoving EF, Mudde AN, de Vries H.

Addict Behav. 2006 Jul;31(7):1177-89. Epub 2005 Oct 19.

PMID:
16242246
2.

Effects of gender on relapse prevention in smokers treated with bupropion SR.

Gonzales D, Bjornson W, Durcan MJ, White JD, Johnston JA, Buist AS, Sachs DP, Rigotti NA, Niaura R, Hays JT, Hurt RD.

Am J Prev Med. 2002 May;22(4):234-9.

PMID:
11988379
3.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
4.

[Factors associated with abstinence in a smoking cessation program].

Tamblay N, Seijas D.

Rev Med Chil. 2008 Feb;136(2):179-85. doi: /S0034-98872008000200006. Epub 2008 May 7. Spanish.

5.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
6.

Smoking cessation: which aids are worthwhile?

van den Berkmortel FW, Bootsma GP, Heijdra YF, van Spiegel PI, Wollersheim H.

Neth J Med. 2000 Nov;57(5):198-205.

PMID:
11063866
7.

Bupropion SR for relapse prevention: a "slips-allowed" analysis.

Durcan MJ, Johnston JA, White J, Gonzales D, Sachs DP, Rigotti N, Niaura R.

Am J Health Behav. 2004 Sep-Oct;28(5):456-63.

PMID:
15482975
8.

Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.

Kotz D, Wagena EJ, Wesseling G.

Respir Med. 2007 Mar;101(3):568-73. Epub 2006 Aug 4.

9.

Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome.

Hurt RD, Wolter TD, Rigotti N, Hays JT, Niaura R, Durcan MJ, Gonzales D, Sachs DP, Johnston JA, Offord KP.

Addict Behav. 2002 Jul-Aug;27(4):493-507.

PMID:
12188588
10.

Smoking cessation in clinical practice: predictors of six-month continuous abstinence in a sample of Greek smokers.

Boutou AK, Tsiata EA, Pataka A, Kontou PK, Pitsiou GG, Argyropoulou P.

Prim Care Respir J. 2008 Mar;17(1):32-8. doi: 10.3132/pcrj.2008.00009.

11.

Cost-effective primary care-based strategies to improve smoking cessation: more value for money.

Salize HJ, Merkel S, Reinhard I, Twardella D, Mann K, Brenner H.

Arch Intern Med. 2009 Feb 9;169(3):230-5; discussion 235-6. doi: 10.1001/archinternmed.2008.556.

PMID:
19204212
12.
13.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
14.

Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies.

Vogt F, Hall S, Marteau TM.

Nicotine Tob Res. 2008 Aug;10(8):1405-13. doi: 10.1080/14622200802239280.

PMID:
18686189
15.

Smoking cessation interventions in clinical practice.

Cornuz J.

Eur J Vasc Endovasc Surg. 2007 Oct;34(4):397-404. Epub 2007 Aug 3. Review.

16.

The prevalence of weight concerns in a smoking abstinence clinical trial.

Clark MM, Hurt RD, Croghan IT, Patten CA, Novotny P, Sloan JA, Dakhil SR, Croghan GA, Wos EJ, Rowland KM, Bernath A, Morton RF, Thomas SP, Tschetter LK, Garneau S, Stella PJ, Ebbert LP, Wender DB, Loprinzi CL.

Addict Behav. 2006 Jul;31(7):1144-52. Epub 2005 Aug 30.

PMID:
16137833
17.

No gender difference in effectiveness of smoking cessation treatment in a Brazilian real-life setting.

Chatkin JM, Abreu CM, Blanco DC, Tonietto R, Scaglia N, Wagner MB, Fritscher CC.

Int J Tuberc Lung Dis. 2006 May;10(5):499-503.

PMID:
16704030
18.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
19.

[Drug and non-drug treatment strategies to assist smoking cessation].

[No authors listed]

Therapie. 2003 Nov-Dec;58(6):479-97. French. No abstract available.

PMID:
15058492
20.

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.

Hoogendoorn M, Welsing P, Rutten-van Mölken MP.

Curr Med Res Opin. 2008 Jan;24(1):51-61.

PMID:
18021492

Supplemental Content

Support Center